文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

年轻女性乳腺癌(YBC):不同种族群体中BRCA1/2突变的患病率及继发恶性肿瘤的风险

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

作者信息

Haffty B G, Choi D H, Goyal S, Silber A, Ranieri K, Matloff E, Lee M H, Nissenblatt M, Toppmeyer D, Moran M S

机构信息

Department of Radiation Oncology, UMDNJ-RWJMS and Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.

出版信息

Ann Oncol. 2009 Oct;20(10):1653-9. doi: 10.1093/annonc/mdp051. Epub 2009 Jun 2.


DOI:10.1093/annonc/mdp051
PMID:19491284
Abstract

BACKGROUND: Despite significant differences in age of onset and incidence of breast cancer between Caucasian (CA), African-American (AA) and Korean (KO) women, little is known about differences in BRCA1/2 mutations in these populations. The purpose of this study is to evaluate the prevalence of BRCA1/2 mutations and the association between BRCA1/2 mutation status and secondary malignancies among young women with breast cancer in these three racially diverse groups. METHODS: Patients presenting to our breast cancer follow-up clinics selected solely on having a known breast cancer diagnosis at a young age (YBC defined as age <45 years at diagnosis) were invited to participate in this study. A total of 333 eligible women, 166 CA, 66 AA and 101 KO underwent complete sequencing of BRCA1/2 genes. Family history (FH) was classified as negative, moderate or strong. BRCA1/2 status was classified as wild type (WT), variant of uncertain significance (VUS) or deleterious (DEL). RESULTS: DEL across these three racially diverse populations of YBC were nearly identical: CA 17%, AA 14% and KO 14%. The type of DEL differed with AA having more frequent mutations in BRCA2, compared with CA and KO. VUS were predominantly in BRCA2 and AA had markedly higher frequency of VUS (38%) compared with CA (10%) and KO (12%). At 10-year follow-up from the time of initial diagnosis of breast cancer, the risk of secondary malignancies was similar among WT (14%) and VUS (16%), but markedly higher among DEL (39%). CONCLUSIONS: In these YBC, the frequency of DEL in BRCA1/2 is remarkably similar among the racially diverse groups at 14%-17%. VUS is more common in AA, but aligns closely with WT in risk of second cancers, age of onset and FH.

摘要

背景:尽管白种人(CA)、非裔美国人(AA)和韩国人(KO)女性在乳腺癌发病年龄和发病率上存在显著差异,但对于这些人群中BRCA1/2基因突变的差异却知之甚少。本研究的目的是评估这三个种族不同的年轻乳腺癌女性群体中BRCA1/2基因突变的患病率,以及BRCA1/2突变状态与继发性恶性肿瘤之间的关联。 方法:仅选择在我们乳腺癌随访诊所就诊且确诊为年轻乳腺癌(YBC定义为诊断时年龄<45岁)的患者参与本研究。共有333名符合条件的女性,其中166名CA、66名AA和101名KO接受了BRCA1/2基因的全序列检测。家族史(FH)分为阴性、中度或强阳性。BRCA1/2状态分为野生型(WT)、意义未明的变异(VUS)或有害(DEL)。 结果:这三个种族不同的年轻乳腺癌人群中DEL的比例几乎相同:CA为17%,AA为14%,KO为14%。DEL的类型有所不同,与CA和KO相比,AA的BRCA2突变更为频繁。VUS主要存在于BRCA2中,与CA(10%)和KO(12%)相比,AA的VUS频率明显更高(38%)。从乳腺癌初次诊断开始随访10年时,WT(14%)和VUS(16%)发生继发性恶性肿瘤的风险相似,但DEL(39%)明显更高。 结论:在这些年轻乳腺癌患者中,不同种族群体的BRCA1/2基因DEL频率非常相似,为14%-17%。VUS在AA中更为常见,但在继发性癌症风险、发病年龄和家族史上与WT密切相关。

相似文献

[1]
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

Ann Oncol. 2009-10

[2]
Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.

J Med Genet. 2006-2

[3]
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.

Prostate Cancer Prostatic Dis. 2018-12-12

[4]
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.

Cancer Res. 2006-8-15

[5]
Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.

Ethn Dis. 2017-4-20

[6]
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.

Fam Cancer. 2012-9

[7]
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.

Breast Cancer Res Treat. 2016-8

[8]
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.

BMC Cancer. 2018-2-6

[9]
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

JAMA. 2005-10-19

[10]
The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer.

Breast Cancer Res Treat. 2020-2-18

引用本文的文献

[1]
Genetic insights into BRCA1/2 associated breast cancer in Türkiye: focus on early-onset and aggressive subtypes.

Discov Oncol. 2025-5-13

[2]
Prognostic nomograms for young breast cancer: A retrospective study based on the SEER and METABRIC databases.

Cancer Innov. 2024-10-25

[3]
Contraception use and changes in young women with newly diagnosed breast cancer.

Fertil Steril. 2025-3

[4]
Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.

Gene. 2024-11-15

[5]
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study.

Lancet Reg Health Eur. 2024-4-24

[6]
Gynecologic Care of Black Breast Cancer Survivors.

Curr Breast Cancer Rep. 2024-3

[7]
mutation status and pathological characterization of breast cancer in Zhoushan Islands, China.

J Int Med Res. 2024-1

[8]
Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea.

Cancer Res Treat. 2024-1

[9]
Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.

Breast Cancer Res. 2023-2-10

[10]
Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis.

Br J Cancer. 2022-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索